Regression of Lung Cancer in Mice by Intranasal Administration of SARS-CoV-2 Spike S1

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 51%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

Could COVID-19 hold a cancer cure? Spikeprotein reduces lung tumors in lab study

Intranasal administration of recombinant SARS-CoV-2 spike S1 causes regression of lung tumor in NNK-insulted female A/J mice. The experimental design is illustrated for NNK-induced lung cancer in A/J mice . Briefly, female A/J mice received two intraperitoneal injections of NNK one week apart. Tumor development was analyzed after 26 weeks of NNK intoxication.

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

physorg_com Lol, so now people will want to catch it? What will be interesting is when people who are vaccinated say “at least the vaccine didn’t work so that I can still catch Covid for its health benefits”!!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Co-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samplesCo-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samples PLOSONE jgi pathogen microbiome SARSCoV2 COVID19 coronavirus covid
Source: NewsMedical - 🏆 19. / 71 Read more »

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2 biorxivpreprint WUSTLmed SARSCoV2 COVID19 coronavirus covid infection
Source: NewsMedical - 🏆 19. / 71 Read more »

Impact of COVID-19 booster vaccination and breakthrough infectionResearchers assessed the protection elicited after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccination or a breakthrough infection against SARS-CoV-2 Omicron variant infection.
Source: NewsMedical - 🏆 19. / 71 Read more »

Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular levelStudy provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level medrxivpreprint WeillCornell SARSCoV2 COVID19 coronavirus covid infection pulmonary
Source: NewsMedical - 🏆 19. / 71 Read more »

Wearing glasses does not reduce risk of COVID-19Wearing glasses does not reduce risk of COVID-19 Coronavirus Disease COVID Glasses EyeGlasses Ophthalmology JAMANetworkOpen Folkehelseinst OsloMet UniBasel Stanford berlinnovation
Source: NewsMedical - 🏆 19. / 71 Read more »

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?Researchers assessed the effect of remdesivir on inpatient COVID-19-associated mortality among individuals hospitalized with SARS-CoV-2 infections in an enormous dataset of US residents beyond clinical trial settings.
Source: NewsMedical - 🏆 19. / 71 Read more »